<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Acquired somatic <z:mp ids='MP_0008867'>uniparental disomy</z:mp> (UPD) is commonly observed in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), myelodysplastic/myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/MPN), or secondary <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (sAML) and may point toward genes harboring mutations </plain></SENT>
<SENT sid="1" pm="."><plain>Recurrent UPD11q led to identification of homozygous mutations in c-<z:chebi fb="0" ids="28911">Cbl</z:chebi>, an E3 ubiquitin ligase involved in attenuation of proliferative signals transduced by activated receptor tyrosine kinases </plain></SENT>
<SENT sid="2" pm="."><plain>We examined the role and frequency of <z:chebi fb="0" ids="28911">Cbl</z:chebi> gene family mutations in MPN and related conditions </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We applied high-density SNP-A karyotyping to identify loss of heterozygosity of 11q in 442 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/MPN, MPN, sAML evolved from these conditions, and primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We sequenced c-<z:chebi fb="0" ids="28911">Cbl</z:chebi>, <z:chebi fb="0" ids="28911">Cbl</z:chebi>-b, and <z:chebi fb="0" ids="28911">Cbl</z:chebi>-c in patients with or without corresponding UPD or deletions and correlated mutational status with clinical features and outcomes </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We identified c-<z:chebi fb="0" ids="28911">Cbl</z:chebi> mutations in 5% and 9% of patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) and sAML, and also in <z:mp ids='MP_0005481'>CML</z:mp> <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> and juvenile myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>Most mutations were homozygous and affected c-<z:chebi fb="0" ids="28911">Cbl</z:chebi>; mutations in <z:chebi fb="0" ids="28911">Cbl</z:chebi>-b were also found in patients with similar clinical features </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:chebi fb="0" ids="28911">Cbl</z:chebi> family mutations showed poor prognosis, with a median survival of 5 months </plain></SENT>
<SENT sid="8" pm="."><plain>Pathomorphologic features included <z:mp ids='MP_0000220'>monocytosis</z:mp>, monocytoid blasts, aberrant expression of phosphoSTAT5, and c-kit overexpression </plain></SENT>
<SENT sid="9" pm="."><plain>Serial studies showed acquisition of c-<z:chebi fb="0" ids="28911">Cbl</z:chebi> mutations during malignant evolution </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Mutations in the <z:chebi fb="0" ids="28911">Cbl</z:chebi> family RING finger domain or linker sequence constitute important pathogenic lesions associated with not only preleukemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e>, and other MPN, but also progression to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, suggesting that impairment of degradation of activated tyrosine kinases constitutes an important <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mechanism </plain></SENT>
</text></document>